R&D/ Views & Analysis/ Views and analysis A new approach to COVID-19 treatment Catherine Longworth ATII, COVID-19, NeuroRx, Relief Therapeutics, respiratory failure, RLF-100, ZYESAMI 0 Comment While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating Share X A new approach to COVID-19 treatment https://pharmaphorum.com/r-d/views-analysis-r-d/a-new-approach-to-covid-19-treatment/
ATII, COVID-19, NeuroRx, Relief Therapeutics, respiratory failure, RLF-100, ZYESAMI
0 Comment
